Research and development expenses were $4,700,000 compared to $6,400,000 in the prior year period and $5,200,000 in the prior quarter. Selling, general and administrative expenses were $2,500,000 in the quarter ended September 30, 2023 compared to $2,400,000 in the prior year quarter and $3,000,000 in the previous quarter. 2nd quarter fiscal 2024 operating loss was $4,100,000 compared to $3,200,000 in the prior year period and $5,100,000 in the prior quarter. 2nd quarter fiscal 2024 net loss included interest and other income of $71,000 and a tax provision of $33,000 compared to interest and other income net of $14,000 and a Tax provision of $37,000 for the same period a year ago. In the preceding Q1, the net loss included Interest and other income net of $80,000 and a cash provision of $51,000 Total second quarter pre tax Stock based compensation expense was $676,000 compared to $661,000 in the comparable quarter a year ago and $820,000 in the prior quarter.